BCBA/MRK (BCBA/MRK)

Buenos Aires Stock Exchange: BCBA/MRK · ARS

ARS 46,760

-79.63 (-0.2%)· Recorded snapshot

Market cap	534.6T
Revenue (ttm)	98.6T
Net income (ttm)	4.7T
EPS (ttm)	ARS 422
P/E (trailing)	110.7x
P/E (forward)	16.7x
Dividend	ARS 631 (1.35%)
Volume	1,091
Beta	0.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 98.6T
Net income (ttm): 4.7T
EPS (ttm): ARS 422
P/E (trailing): 110.7x
P/E (forward): 16.7x
Market cap: 534.6T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E16.7

P25 n/aP50 n/aP75 n/a

Trailing P/E110.7

P25 n/aP50 n/aP75 n/a

ROE7

P25 n/aP50 n/aP75 n/a

ROIC14.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/MRK indicators

Market & fundamental data

Available fields

251

Groups with data

Currency

USD

Showing 251 of 251 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-29
Employees	75,000
Employees change	0
Employees growth	0%
Enterprise value	ARS 606.5T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1891
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT110277
Last earnings date	2026-10-29
Last refreshed	2026-10-29
Market cap	ARS 534.6T
Next earnings date	2026-10-29
Price	ARS 46,760.00
Price currency	ARS
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bcba/MRK
Website	https://www.merck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	56.04x
Average P/E ratio (3Y)	100.29x
Average P/E ratio (5Y)	71.09x
Earnings yield	0.9%
EV/Earnings	129.03x
EV/EBIT	16.8x
EV/EBITDA	13.47x
EV/FCF	25.49x
EV/Sales	5.93x
FCF / EV yield	3.92%
FCF yield	4.45%
Forward P/E	16.73x
Graham number	7095.03705
Graham upside	-84.83%
Lynch fair value	ARS 2,056.02
Lynch upside	-95.6%
P/(FCF - SBC) ratio	23.78x
P/(OCF - SBC) ratio	18.92x
P/B ratio	8.59x
P/E ratio	110.72x
P/FCF ratio	22.46x
P/OCF ratio	18.07x
P/S ratio	5.42x
Price/EBITDA ratio	12.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.28%
EBITDA margin	43.37%
Effective tax rate	46.72%
FCF margin	23.19%
Gross margin	75.9%
Operating margin	35.28%
Pretax margin	8.94%
Profit margin	4.77%
Profit per employee	ARS 63.5M
Profitable years	35
Revenue per employee	ARS 1.3B
ROA	11.87%
ROA (5Y)	11.18%
ROCE	23.01%
ROE	6.96%
ROE (5Y)	30.37%
ROIC	14.05%
ROIC (5Y)	22.36%
SBC / revenue	1.34%
Tax / revenue	4.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-80.37%
EPS growth 10Y	-3.53%
EPS growth 3Y	1.25%
EPS growth 5Y	-10.38%
EPS growth years	2
FCF growth	9.11%
FCF growth (Q)	77.03%
FCF growth (QoQ)	52.96%
FCF growth 3Y	14.05%
FCF growth 5Y	18.23%
Gross profit growth	2.6%
Gross profit growth (Q)	0.52%
Gross profit growth 3Y	5.77%
Gross profit growth 5Y	9.69%
Net income growth	-80.66%
Net income growth 3Y	0.66%
Net income growth 5Y	-10.64%
Net income growth years	2
OCF growth	7.73%
OCF growth (Q)	63.07%
OCF growth (QoQ)	37.06%
OCF growth 10Y	5.83%
OCF growth 3Y	9.82%
OCF growth 5Y	10.91%
Operating income growth	-1.53%
Operating income growth 3Y	5.7%
Operating income growth 5Y	13.81%
Revenue growth	4.64%
Revenue growth (Q)	5.07%
Revenue growth (QoQ)	1.97%
Revenue growth 10Y	5.37%
Revenue growth 3Y	4.51%
Revenue growth 5Y	8.68%
Revenue growth quarters	4
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -5.8T
Depreciation and amortization	ARS 8.3T
EBIT	ARS 34.8T
EBITDA	ARS 42.8T
EPS	ARS 422.32
Financing cash flow	ARS 9.1T
Free cash flow	ARS 23.8T
Free cash flow minus SBC	ARS 22.5T
Gross profit	ARS 74.9T
Income taxes	ARS 4.1T
Investing cash flow	ARS -40.4T
Net borrowing	ARS 28.8T
Net cash flow	ARS -1.8T
Net income	ARS 4.7T
Operating cash flow minus SBC	ARS 28.3T
Operating income	ARS 34.8T
Revenue	ARS 98.6T
Stock-based compensation	ARS 1.3T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.6
Book value per share	ARS 25,165.13
Debt / EBITDA	1.84
Debt / equity	1.28
Debt / FCF	3.36
Goodwill	ARS 33.3T
Interest coverage	13.47
Long-term assets	ARS 135.8T
Long-term liabilities	ARS 87.4T
Net cash (debt)	ARS -69.3T
Net cash / market cap	-12.96%
Net debt / EBITDA	1.62
Net debt / equity	1.11
Net debt / FCF	2.91
Piotroski F-Score	4
Property, plant and equipment	ARS 39.7T
Shareholders' equity	ARS 62.2T
Tangible book value	ARS -6.9T
Tangible book value per share	ARS -2,776.79
Total assets	ARS 192.3T
Total cash	ARS 10.6T
Total debt	ARS 79.9T
Total liabilities	ARS 130.1T
WACC	4.98%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	ARS 56.5T
Current liabilities	ARS 42.8T
Current ratio	1.32
Inventory turnover	2.51
Net working capital	ARS 6.9T
Quick ratio	0.74
Working capital	ARS 13.3T
Working capital turnover	9,874.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.92%
Dividend growth	27.92%
Dividend growth (10Y)	82.71%
Dividend growth (3Y)	90.85%
Dividend growth (5Y)	15.24%
Dividend growth years	3
Dividend payment date	2026-10-07
Dividend payment years	29
Dividend payout frequency	Quarterly
Dividend per share	ARS 630.95
Dividend yield	1.35%
Ex-dividend date	2026-09-15
Last dividend	ARS 164.62
Payout ratio	261.52%
Shareholder yield	3.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	48,786.57%
10Y return CAGR	91.06%
10Y total return	64,665.21%
150-day SMA	ARS 40,325.43
15Y price change	314,782.16%
15Y return CAGR	75.23%
15Y total return	451,145.29%
1D price change	-0.17%
1M price change	-2.79%
1M total return	-2.79%
1W price change	-4.49%
1W total return	-4.49%
1Y price change	82.94%
1Y return CAGR	86.65%
1Y total return	86.57%
20-day SMA	ARS 46,929.00
200-day SMA	ARS 38,814.98
20Y price change	359,592.31%
20Y return CAGR	54.31%
20Y total return	585,983.38%
3M price change	11.71%
3M total return	12.33%
3Y price change	167.06%
3Y return CAGR	41.28%
3Y total return	182.06%
50-day SMA	ARS 47,379.90
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 50,600.00
52-week high date	2026-10-22
52-week low	ARS 25,000.00
52-week low date	2025-11-04
5Y price change	1,312.69%
5Y return CAGR	72.44%
5Y total return	1,424.03%
6M price change	39.67%
6M total return	41.05%
All-time high	ARS 50,600.00
All-time high date	2026-10-22
All-time low	ARS 5.74
All-time low date	2000-03-06
Average true range (ATR)	ARS 1,305.88
Average volume	2.3K
Beta (5Y)	0.22
Change from 52-week high	-7.59%
Change from 52-week low	100.69%
Change from all-time high	-7.59%
Change from all-time low	814,534.15%
Change from open	-0.13%
Day's gap	-0.04%
Dollar volume	ARS 51M
High price	ARS 47,200.00
Low price	ARS 46,400.00
Monthly RSI	77.08
Open price	ARS 46,820.00
Position in 52-week range	45%
Previous close	ARS 46,840.00
Price vs 150-day SMA	15.96%
Price vs 20-day SMA	-0.36%
Price vs 200-day SMA	20.47%
Price vs 50-day SMA	-1.31%
Relative volume	0.43
RSI	48.17
Sharpe ratio	1.87
Sharpe ratio (3Y)	1.03
Sharpe ratio (5Y)	1.6
Sortino ratio	3.46
Sortino ratio (3Y)	1.75
Sortino ratio (5Y)	2.66
Volume	1.1K
Weekly RSI	63.52
YTD price change	44.86%
YTD total return	46.95%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.5B
Shares change (QoQ)	-0.08%
Shares change (YoY)	-1.92%
Shares held by insiders	0.05%
Shares held by institutions	81.22%
Short ratio	2.6 days

Deeper analysis on BCBA/MRK

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/MRK report

Is a complete BCBA/MRK research report available?

No complete published report is available for bcba/MRK (BCBA/MRK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/MRK (BCBA/MRK)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/MRK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/MRK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/MRK

Frequently asked questions